A phase 2 umbrella study of retifanlimab (incmga00012) alone or in combination with other therapies in patients with advanced or metastatic endometrial cancer (pod1um-204)
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要